EssilorLuxottica reported a 4.0% revenue growth at constant exchange rates for the third quarter of 2024, falling short of market expectations. The eyewear giant's sales rose to €6.44 billion, with North America showing particularly weak performance. Despite the slowdown, all regions and business segments remained positive, with notable achievements in the EMEA region and solid growth in China, bolstered by Stellest technology. The company continues to focus on innovation as a key growth driver, introducing products like Ray-Ban Meta and Transitions Gen S, while making strides in myopia management and smart glasses technology.
Strategic Moves Bolster Market Position
The acquisition of specialized firms and partnerships with tech companies are strengthening EssilorLuxottica's foothold in the med-tech sector and digital eyewear market. These strategic moves, coupled with the company's commitment to innovation, underscore its determination to lead the industry's transformation. Despite current challenges, management remains confident in achieving long-term objectives. The stock experienced a slight dip of 0.51% to €215.35 on October 17, 2024, but maintains a robust year-to-date performance with a 29.91% increase, reflecting investor confidence in the company's future prospects.
Ad
EssilorLuxottica Stock: New Analysis - 18 OctoberFresh EssilorLuxottica information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Read our updated EssilorLuxottica analysis...